Study guide

11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4

Nursing and Midwifery Council of Ghana Licensing Examinations Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: N&MC Ghana Regulation, Licensing Pathway & Examination Format

1.1 Health Professions Regulatory Bodies Act, 2013 (Act 857) & the N&MC Mandate 1.2 Cadres, Indexing, Eligibility, Examination Windows & Fees 1.3 Registration, PIN vs. AIN, Rotation, Licence Renewal & Foreign-Trained Pathway 1.4 Examination Format: Computer-Based Papers, Practical Component, Results & Re-sits

2 Chapter 2: Professional Ethics, Law, Leadership & Patient Rights

2.1 N&MC Ghana Code of Conduct, Ethical Principles & Professional Boundaries 2.2 Ghana Health Service Patients' Charter, Informed Consent & Confidentiality 2.3 Clinical Documentation, Incident Reporting, Negligence & Legal Liability 2.4 Nursing Leadership, Ward Management, Handover & Team Communication

3 Chapter 3: Infection Prevention, Control & Healthcare Safety

3.1 Standard & Transmission-Based Precautions, Hand Hygiene & PPE 3.2 Sterilization, Decontamination & Healthcare Waste Management in Ghana 3.3 Injection Safety, Sharps Injury Prevention & Occupational Post-Exposure Prophylaxis

4 Chapter 4: Clinical Nursing Foundations, Nursing Process & Practical Skills

4.1 Vital Signs Assessment, Clinical Deterioration & Early Warning Scoring 4.2 Medication Administration, Dosages, High-Alert Drugs & Pharmacovigilance 4.3 Enteral & Parenteral Nutrition, Fluid and Electrolyte Balance & Acid-Base Disorders 4.4 Pain Assessment, Analgesic Ladder & Palliative Care in Ghana 4.5 Nursing Process, Care Plans, Care Study & the Practical Examination

5 Chapter 5: Respiratory, Cardiovascular & Neurological Nursing

5.1 Airway, Breathing & Oxygen Therapy: Asthma, COPD & Pneumonia 5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications 5.3 Hypertension Management, Hypertensive Emergencies & Stroke Care 5.4 Neurological Nursing: Unconscious Patient, Head Injury, Raised ICP & Epilepsy

6 Chapter 6: Endocrine, Renal, Gastrointestinal & Liver Disorders

6.1 Diabetes Mellitus, DKA, HHS & Glycemic Emergencies 6.2 Acute Kidney Injury, Chronic Kidney Disease & Fluid Overload 6.3 Acute Abdomen, Peptic Ulcer Disease & Gastrointestinal Bleeding 6.4 Liver Disease (Hepatitis B, Cirrhosis, Hepatic Encephalopathy) & Thyroid Disorders

7 Chapter 7: Endemic Tropical Infections & Communicable Diseases

7.1 Malaria Management: Diagnostics, Uncomplicated & Severe Malaria Protocols 7.2 Tuberculosis Diagnosis, DOTS Protocol & Infection Control 7.3 HIV/AIDS Management, Antiretroviral Therapy (ART) & Opportunistic Infections 7.4 Enteric Infections: Cholera, Typhoid Fever & Diarrhoea Outbreak Response

8 Chapter 8: Hematology & Common Non-Communicable Conditions

8.1 Sickle Cell Disease: Vaso-Occlusive Crises, Anemia & Organ Protection 8.2 Blood Transfusion Practice, Crossmatching & Transfusion Reactions 8.3 Venous Thromboembolism, Anticoagulation & Pressure Injury Prevention

9 Chapter 9: Perioperative, Urological & Gynaecological Surgical Nursing

9.1 Preoperative Evaluation, Patient Preparation & Informed Consent 9.2 Intraoperative Care, Surgical Asepsis & WHO Surgical Safety Checklist 9.3 Postoperative Complications, Wound Healing & Dressing Techniques 9.4 Anesthesia Overview, Recovery Room (PACU) Care & Pain Management 9.5 Urological Surgical Nursing: Retention, BPH, Prostatectomy, Calculi & Catheter Care 9.6 Gynaecological Nursing: Ectopic Pregnancy, Abortion Care, Fibroids, PID & Cancer Screening

10 Chapter 10: Trauma, Burns & Acute Emergency Management

10.1 ABCDE Primary/Secondary Survey & Disaster Triage (START) 10.2 Major Burns: Rule of Nines, Parkland Fluid Resuscitation & Wound Care 10.3 Fractures, Immobilization, Compartment Syndrome & Spinal Precautions 10.4 Environmental Emergencies: Snakebites, Poisoning & Tetanus Prophylaxis

11 Chapter 11: Maternal Health, Obstetric & Postnatal Nursing

11.1 Antenatal Care (ANC/FANC), Risk Assessment & Health Promotion 11.2 Normal Labor, Stages & Partograph Monitoring 11.3 Obstetric Complications: Postpartum Hemorrhage (PPH) & Active Third Stage (AMTSL) 11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4 11.5 Postnatal Care, Breastfeeding Support & Family Planning

12 Chapter 12: Neonatal & Pediatric Nursing Care

12.1 Immediate Newborn Care, APGAR Scoring & Neonatal Resuscitation 12.2 Integrated Management of Neonatal & Childhood Illness (IMNCI) 12.3 Ghana Expanded Programme on Immunization (EPI) & Pediatric Malnutrition

13 Chapter 13: Community Health Nursing & Primary Healthcare in Ghana

13.1 Community-Based Health Planning and Services (CHPS) Model 13.2 Disease Surveillance, Epidemic Preparedness & Community Health Education 13.3 Environmental Sanitation, Water Safety & School Health Services

14 Chapter 14: Mental Health Nursing & Psychiatric Care

14.1 Mental Health Act, 2012 (Act 846): Authority, Admission Routes & Rights 14.2 Common Psychiatric Disorders: Depression, Bipolar, Schizophrenia & Psychosis 14.3 Psychiatric Emergencies: Suicide Risk Assessment & De-escalation

11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4

Key Takeaways Explain This Topic AI

Hypertensive disorders of pregnancy are categorized into Chronic Hypertension (pre-existing before pregnancy or < 20 weeks), Gestational Hypertension (new BP >= 140/90 mmHg at > 20 weeks without proteinuria), Preeclampsia (hypertension at > 20 weeks with proteinuria or end-organ dysfunction), and Eclampsia (new-onset generalized seizures).

Severe features of preeclampsia include BP >= 160/110 mmHg, persistent frontal headache, visual disturbances, severe epigastric or right upper quadrant pain from Glisson's capsule distension, pulmonary edema, thrombocytopenia (< 100,000/uL), and elevated liver transaminases.

HELLP syndrome is a life-threatening variant featuring microangiopathic Hemolysis (schistocytes, elevated LDH/bilirubin), Elevated Liver enzymes (AST/ALT twice normal), and Low Platelets (< 100,000/uL), carrying high risk of DIC and hepatic hematoma rupture.

Magnesium Sulfate (MgSO4) is the anticonvulsant gold standard for preventing and treating eclamptic seizures; the standard Pritchard regimen administers a 14g loading dose (4g IV 20% solution over 5-10 minutes plus 10g IM [5g 50% solution in each buttock]), followed by 5g IM every 4 hours for 24 hours post-delivery or post-convulsion.

Prior to each MgSO4 maintenance dose, the nurse must verify three vital clinical criteria: respiratory rate >= 16 breaths/min, presence of patellar (knee-jerk) reflexes, and hourly urine output >= 30 mL/hr; immediate antidote administration (10 mL of 10% Calcium Gluconate IV slowly over 10 minutes) is mandatory if toxicity develops.

Last updated: September 2026

11.4 Hypertensive Disorders of Pregnancy: Preeclampsia, Eclampsia & MgSO4

Quick Answer: Hypertensive disorders in pregnancy span chronic hypertension (< 20 weeks), gestational hypertension (> 20 weeks without proteinuria), preeclampsia (> 20 weeks with proteinuria or maternal end-organ failure), and eclampsia (generalized tonic-clonic convulsions). Severe preeclampsia features BP ≥ 160/110 mmHg, intractable headache, visual changes, severe epigastric pain, pulmonary edema, and HELLP syndrome. The definitive anticonvulsant is Magnesium Sulfate (MgSO4) via the Pritchard regimen (14 g loading dose: 4 g IV over 5–10 min + 10 g IM; then 5 g IM 4-hourly for 24 hours). Mandatory pre-dose safety checks require respiratory rate ≥ 16 bpm, active patellar reflexes, and urine output ≥ 30 mL/hr. If toxicity strikes, stop MgSO4 and administer Calcium Gluconate 10% (10 mL slow IV over 10 min).

Classification and Diagnostic Spectrum of Hypertensive Disorders in Pregnancy

Hypertensive disorders of pregnancy represent one of the most perilous obstetrical challenges in Ghana, contributing substantially to maternal and perinatal morbidity and mortality. Accurate categorization is essential for targeted management.

Hypertensive Classification Gestational Age at Onset Significant Proteinuria Defining Clinical Features

Chronic Hypertension Pre-dating pregnancy or diagnosed < 20 weeks Absent (unless baseline renal disease exists) Persists > 12 weeks postpartum; blood pressure ≥ 140/90 mmHg.

Gestational Hypertension Diagnosed ≥ 20 weeks Absent New-onset BP ≥ 140/90 mmHg without systemic organ dysfunction; resolves within 12 weeks postpartum.

Preeclampsia Diagnosed ≥ 20 weeks Present (≥ 1+ on dipstick or ≥ 300 mg/24h) New-onset BP ≥ 140/90 mmHg accompanied by proteinuria OR new end-organ dysfunction.

Eclampsia Diagnosed ≥ 20 weeks or early postpartum Present in vast majority New-onset generalized tonic-clonic convulsions or coma in a preeclamptic woman not due to coincidental CNS pathology.

Chronic Hypertension with Superimposed Preeclampsia Pre-existing chronic hypertension New-onset or sudden worsening Sudden surge in baseline BP, new-onset proteinuria, or acute development of thrombocytopenia or elevated liver transaminases.

Pathophysiology of Preeclampsia and Multi-Organ Dysfunction

Preeclampsia is primarily a disease of the placenta. The cascade begins during early implantation (10–16 weeks):

Failed Spiral Artery Remodeling: Normal cytotrophoblast invasion transforms high-resistance, muscular maternal spiral arteries into dilated, flaccid, low-resistance vessels. In preeclampsia, trophoblastic invasion is incomplete; the spiral arteries remain narrow and muscular;

Placental Ischemia & Reperfusion Injury: Inadequate placental perfusion generates oxidative stress, causing hypoxic trophoblasts to release circulating toxic anti-angiogenic factors (soluble fms-like tyrosine kinase-1 [sFlt-1] and soluble endoglin) into the maternal circulation;

Systemic Endothelial Cell Injury: Circulating factors neutralize Vascular Endothelial Growth Factor (VEGF) and Placental Growth Factor (PlGF), precipitating widespread endothelial cell dysfunction;

Widespread Vasospasm & Capillary Leak: Endothelial injury causes loss of nitric oxide, prostacyclin depletion, and intravascular fluid transudation into interstitial spaces (edema), with activation of the coagulation cascade and progressive end-organ hypoperfusion (kidneys, liver, brain, placenta).

Preeclampsia with Severe Features

Preeclampsia can rapidly escalate into a life-threatening, multi-system crisis. The presence of any one of the following criteria confirms preeclampsia with severe features :

Severe Blood Pressure Elevation: Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 110 mmHg recorded on two occasions at least 4 hours apart while the client is on bed rest;

Neurological / Cerebral Symptoms: Persistent, severe frontal or occipital headache unresponsive to standard analgesics; visual disturbances including photophobia, scotomata (blind spots), blurred vision, diplopia, or cortical blindness;

Hepatic Injury: Severe, persistent epigastric or right upper quadrant abdominal pain refractory to medication (caused by hepatocellular necrosis, subcapsular hematoma, and stretching of Glisson's capsule); elevated serum transaminases (AST or ALT twice the upper limit of normal);

Hematological Dysfunction (Thrombocytopenia): Platelet count < 100,000/µL;

Renal Insufficiency: Serum creatinine > 1.1 mg/dL (> 97 µmol/L) or a doubling of baseline serum creatinine in the absence of other renal disease;

Pulmonary Edema: Sudden onset of severe dyspnea, tachypnea, orthopnea, and coarse crackles on auscultation, driven by high capillary hydrostatic pressure and reduced colloid oncotic pressure.

HELLP Syndrome: A Catastrophic Variant

HELLP syndrome is an acute, life-threatening manifestation of severe microvascular endothelial injury affecting 10–20% of women with severe preeclampsia:

H (Hemolysis): Microangiopathic hemolytic anemia. Erythrocytes are fragmented as they traverse damaged, fibrin-mesh microvasculature, producing schistocytes on peripheral smear, elevated indirect bilirubin (≥ 1.2 mg/dL), and high lactate dehydrogenase ( LDH > 600 U/L );

EL (Elevated Liver Enzymes): Severe hepatocellular injury causing AST or ALT ≥ 70 U/L or twice the institutional baseline;

LP (Low Platelets): Consumptive thrombocytopenia with platelet count < 100,000/µL .

Complications: Disseminated Intravascular Coagulation (DIC), subcapsular liver hematoma rupture, acute renal failure, and placental abruption.

Emergency Nursing and Medical Care of Eclampsia

Eclampsia constitutes an absolute obstetric emergency. When a convulsion occurs, the nurse must maintain composure and execute immediate life-support protocols.

Step-by-Step Acute Seizure Management (The ABCs)

Call for Immediate Help: Summon the emergency obstetric team and resuscitation kit. Never leave the convulsing woman alone ;

Positioning & Airway: Turn the woman onto her left lateral side with the head tilted slightly downward. This position prevents tongue obstruction, enhances venous return by relieving aortocaval compression, and allows vomitus or saliva to drain freely, preventing fatal aspiration pneumonia;

Protect from Injury: Cushion the bed rails with pillows or blankets. Gently guide limbs to avoid physical trauma; never forcibly restrain the client and never force hard mouth gags or spatulas between clenched teeth (which can dislodge teeth, cause tongue trauma, and occlude the airway);

Oxygenation: As soon as the convulsion ceases, gently suction secretions from the oropharynx. Administer high-flow oxygen at 8 to 10 L/minute via a non-rebreather face mask to reverse maternal and fetal hypoxia;

Intravenous Access & Monitoring: Establish wide-bore IV access; connect pulse oximeter, blood pressure cuff, and continuous fetal heart rate monitoring.

Anticonvulsant Therapy: Magnesium Sulfate (MgSO4) Protocol

Magnesium Sulfate (MgSO4) is the uncontested, evidence-based gold standard for both the prevention of seizures in severe preeclampsia and the treatment of eclamptic convulsions. The landmark international Collaborative Eclampsia Trial confirmed MgSO4 is dramatically superior to diazepam and phenytoin in halving recurrent convulsions and reducing maternal mortality.

Mechanism of Action

Magnesium Sulfate acts as a potent central and peripheral neuroprotective agent:

Antagonizes central N-methyl-D-aspartate (NMDA) glutamate receptors, suppressing neuronal excitability and seizure discharge;

  • Induces potent cerebral arterial vasodilation, reversing cerebral ischemia and vasospasm;
  • Protects blood-brain barrier integrity, reducing vasogenic cerebral edema;

Blocks presynaptic release of acetylcholine at the neuromuscular junction, attenuating peripheral muscle twitching.

The Standard Pritchard Regimen (IV + IM)

The Pritchard regimen is the preferred protocol across Ghana Health Service facilities due to its proven efficacy, safety profile, and feasibility in settings without electronic syringe pumps: +-----------------------------------------------------------------------------------------+

  • | PRITCHARD REGIMEN PROTOCOL |
  • | |
  • | LOADING DOSE: |
  • | - IV: 4 g of 20% solution slow IV push over 5-10 minutes |
  • | - IM: 10 g of 50% solution (5 g in each buttock deep IM with 1 mL 2% lidocaine) |
  • | |
  • | MAINTENANCE DOSE: |
  • | - 5 g of 50% solution deep IM in alternating buttocks every 4 hours |
  • | |
  • | DURATION: Continue for 24 hours after delivery OR 24 hours after last convulsion |
  • +-----------------------------------------------------------------------------------------+

Loading Dose (Total 14 g):

Intravenous Component: 4 g IV administered as a 20% solution over 5 to 10 minutes (prepared by drawing 8 mL of 50% MgSO4 [4 g] and diluting with 12 mL sterile water to make 20 mL of 20% solution);

Intramuscular Component: 10 g IM administered immediately following the IV bolus—inject 5 g (10 mL of 50% MgSO4) deep IM into the upper outer quadrant of each buttock (total 10 g in two buttocks) using a long 20G/21G needle. Add 1 mL of 2% lidocaine to each syringe to mitigate intense local injection pain;

Maintenance Dose (5 g IM Every 4 Hours):

Administer 5 g (10 mL of 50% solution) deep IM in alternating buttocks every 4 hours ;

Duration of Maintenance:

Continued uninterrupted for 24 hours following delivery or 24 hours following the last convulsion , whichever occurs later;

Managing Recurrent Seizures:

If a seizure recurs after 15 minutes of the loading dose, administer an additional 2 g of 20% MgSO4 IV slowly over 5 minutes.

Monitoring for Magnesium Toxicity & Antidote Protocol

Caution

Critical Nursing Concept: Renal Excretion & Toxic Accumulation Magnesium Sulfate is excreted exclusively by the kidneys via glomerular filtration . Preeclamptic women frequently exhibit renal impairment and oliguria; if glomerular filtration falls, magnesium accumulates rapidly in maternal serum, progressing from loss of reflexes to lethal respiratory arrest and asystole!

The Three Mandatory Pre-Requisites Before Every Maintenance Dose

Before administering each 4-hourly intramuscular maintenance dose, the nurse must assess, verify, and document the following three clinical parameters:

Patellar / Knee-Jerk Reflex: Must be clearly present . Loss of deep tendon reflexes is the earliest and most sensitive clinical sign of magnesium toxicity (occurring at serum levels of 8–10 mEq/L);

Respiratory Rate: Must be ≥ 16 breaths per minute . Magnesium-induced neuromuscular blockade paralyzes respiratory musculature, causing respiratory depression (< 12 breaths/min) at levels of 12–15 mEq/L;

Hourly Urine Output: Must be ≥ 30 mL/hour over the preceding 4 hours (or ≥ 100 mL accumulated over 4 hours). If urine output is < 30 mL/hr, magnesium cannot be excreted and will rapidly reach toxic concentrations.

Action if ANY parameter is abnormal: Withhold the maintenance dose immediately and alert the obstetrician.

Emergency Protocol for Magnesium Toxicity

If the client exhibits loss of patellar reflexes, respiratory depression (< 16 breaths/min), or cardiac arrhythmia:

Stop Magnesium Sulfate immediately ;

Administer the Specific Antidote:

  • Give Calcium Gluconate 10% ;
  • Dose: 1 g (10 mL of 10% solution) by slow IV push over 10 minutes ;
  • Calcium directly antagonizes the neuromuscular and cardiac blocking actions of magnesium;

Support Resuscitation: Provide bag-valve-mask assisted ventilation or endotracheal intubation with 100% oxygen if respiratory failure is present.

Antihypertensive Therapy for Severe Hypertension

Antihypertensive therapy is indicated immediately for severe hypertension (Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 110 mmHg) to prevent intracranial hemorrhage (maternal stroke), encephalopathy, and placental abruption.

Treatment Target: Lower blood pressure smoothly to a target diastolic range of 90 to 100 mmHg (and systolic 135–145 mmHg). Never drop blood pressure precipitously, as sudden maternal hypotension impairs uteroplacental perfusion, causing acute fetal bradycardia and distress.

First-Line Pharmacological Agents in Ghana:

Hydralazine: 5 to 10 mg slow IV over 2 minutes; repeat 5–10 mg every 20–30 minutes until target BP is achieved (maximum cumulative dose: 20–30 mg);

Labetalol: 20 mg IV bolus over 2 minutes; if response is inadequate after 10 minutes, escalate to 40 mg, then 80 mg every 10 minutes (maximum dose: 300 mg). Contraindicated in asthma, congestive heart failure, and second/third-degree heart block;

Oral Immediate-Release Nifedipine: 10 mg capsule swallowed whole (do NOT chew, bite, or administer sublingually); repeat in 30 minutes if needed.

Definitive Management: Timely Delivery

Delivery of the fetus and placenta is the only definitive cure for preeclampsia and eclampsia. Once maternal stabilization is accomplished—seizures controlled with MgSO4, hypoxia corrected, and severe hypertension mitigated—the obstetric team plans definitive delivery regardless of gestational age in eclampsia or severe refractory preeclampsia. Vaginal delivery with cervical ripening is favored when feasible, reserving emergency Cesarean section for obstetric indications or fetal decompensation.